530 related articles for article (PubMed ID: 7568001)
21. Constitutive association of JAK1 and STAT5 in pro-B cells is dissolved by interleukin-4-induced tyrosine phosphorylation of both proteins.
Erhardt I; Lischke A; Sebald W; Friedrich K
FEBS Lett; 1998 Nov; 439(1-2):71-4. PubMed ID: 9849880
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.
Lejeune D; Dumoutier L; Constantinescu S; Kruijer W; Schuringa JJ; Renauld JC
J Biol Chem; 2002 Sep; 277(37):33676-82. PubMed ID: 12087100
[TBL] [Abstract][Full Text] [Related]
23. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.
Bacon CM; Tortolani PJ; Shimosaka A; Rees RC; Longo DL; O'Shea JJ
FEBS Lett; 1995 Aug; 370(1-2):63-8. PubMed ID: 7544303
[TBL] [Abstract][Full Text] [Related]
24. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis.
Bauer JH; Liu KD; You Y; Lai SY; Goldsmith MA
J Biol Chem; 1998 Apr; 273(15):9255-60. PubMed ID: 9535918
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells.
Foxwell BM; Beadling C; Guschin D; Kerr I; Cantrell D
Eur J Immunol; 1995 Nov; 25(11):3041-6. PubMed ID: 7489741
[TBL] [Abstract][Full Text] [Related]
26. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.
Liu J; Kern JA
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):306-13. PubMed ID: 12204892
[TBL] [Abstract][Full Text] [Related]
27. Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatases.
Zhang H; Conrad DM; Butler JJ; Zhao C; Blay J; Hoskin DW
J Immunol; 2004 Jul; 173(2):932-44. PubMed ID: 15240680
[TBL] [Abstract][Full Text] [Related]
28. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation.
Cohney SJ; Sanden D; Cacalano NA; Yoshimura A; Mui A; Migone TS; Johnston JA
Mol Cell Biol; 1999 Jul; 19(7):4980-8. PubMed ID: 10373548
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
Beadling C; Ng J; Babbage JW; Cantrell DA
EMBO J; 1996 Apr; 15(8):1902-13. PubMed ID: 8617237
[TBL] [Abstract][Full Text] [Related]
30. TGF-beta does not inhibit IL-12- and IL-2-induced activation of Janus kinases and STATs.
Sudarshan C; Galon J; Zhou Y; O'Shea JJ
J Immunol; 1999 Mar; 162(5):2974-81. PubMed ID: 10072548
[TBL] [Abstract][Full Text] [Related]
31. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
[TBL] [Abstract][Full Text] [Related]
32. Jak-STAT signaling induced by the v-abl oncogene.
Danial NN; Pernis A; Rothman PB
Science; 1995 Sep; 269(5232):1875-7. PubMed ID: 7569929
[TBL] [Abstract][Full Text] [Related]
33. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation.
Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H
J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069
[TBL] [Abstract][Full Text] [Related]
34. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells.
Demoulin JB; Uyttenhove C; Lejeune D; Mui A; Groner B; Renauld JC
Cancer Res; 2000 Jul; 60(14):3971-7. PubMed ID: 10919676
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
Bianchi M; Meng C; Ivashkiv LB
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9573-8. PubMed ID: 10920190
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes.
Bacon CM; Petricoin EF; Ortaldo JR; Rees RC; Larner AC; Johnston JA; O'Shea JJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7307-11. PubMed ID: 7638186
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid.
Chen CW; Chao Y; Chang YH; Hsu MJ; Lin WW
Br J Pharmacol; 2002 Dec; 137(7):1011-20. PubMed ID: 12429573
[TBL] [Abstract][Full Text] [Related]
38. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
Bright JJ; Kerr LD; Sriram S
J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cytokine production and interference in IL-2 receptor-mediated Jak-Stat signaling by the hydroxylamine metabolite of sulfamethoxazole.
Hess DA; O'Leary EF; Lee JT; Almawi WY; Madrenas J; Rieder MJ
FASEB J; 2001 Aug; 15(10):1855-7. PubMed ID: 11481253
[No Abstract] [Full Text] [Related]
40. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
